FindTrial
Sign In

Prednisolone Acetate 1% Oph Susp

DRUG10 trials

Sponsors

Bausch & Lomb Incorporated, University of Utah, SR Cornea Consultants, The New York Eye Surgery Center, The Cleveland Clinic

Conditions

Anterior Chamber InflammationCME - Cystoid Macular EdemaCataractCataract DiabeticConjunctivitis, Giant PapillaryConjunctivitis, Seasonal AllergicCorneal DefectCorneal Edema

Phase 4

A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
CompletedNCT01437982
Bausch & Lomb IncorporatedConjunctivitis, Giant Papillary, Conjunctivitis, Seasonal Allergic, Inflammation
Start: 2010-08-05End: 2015-10-19Target: 140Updated: 2019-11-19
Loteprednol vs. Prednisolone and Fluorometholone
CompletedNCT03123614
University of UtahCorneal Opacity, Intraocular Pressure
Start: 2014-09-19End: 2018-07-31Updated: 2021-05-26
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
CompletedNCT04184999
SR Cornea ConsultantsDry Eye Syndromes
Start: 2019-08-10End: 2019-12-01Updated: 2023-11-22
Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
TerminatedNCT04200651
The New York Eye Surgery CenterCataract, Glaucoma
Start: 2020-01-13End: 2023-07-12Updated: 2024-01-31
Dextenza in the Post-op Management of Vitreoretinal Surgeries
RecruitingNCT04371445
The Cleveland ClinicOcular Inflammation, Post-Operative Inflammation, Post-operative Pain +1
Start: 2020-06-01End: 2026-05-01Target: 30Updated: 2026-02-10
DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses
CompletedNCT04479748
Prism Vision GroupCataract
Start: 2020-10-01End: 2022-12-12Updated: 2023-06-22
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
CompletedNCT04521140
Nicole Fram M.D.Anterior Chamber Inflammation, Corneal Defect, Corneal Edema +4
Start: 2020-10-16End: 2023-01-04Updated: 2023-07-24
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
WithdrawnNCT04977427
Baylor Research InstituteCataract Diabetic, Macula Edema
Start: 2021-08-31End: 2021-12-20Updated: 2026-03-02
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
CompletedNCT05626478
Nicole Fram M.D.Anterior Chamber Inflammation, CME - Cystoid Macular Edema, Corneal Defect +4
Start: 2023-06-01End: 2025-02-05Updated: 2026-02-20

Unknown Phase

The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman Syndrome
NCT04590183
Peking UniversityPosner Schlossman Syndrome
Start: 2020-10-01End: 2021-09-30Target: 30Updated: 2021-08-16